proteolytic mAbs (Cytodesign)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameproteolytic mAbs (Cytodesign)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionBotulinum toxin inhibitors

TargetsBotulinum toxin

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCytodesign Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCytodesign Inc

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A